). The effect of a 103Q Htt ex1 polyQ expansion is also apparent when expressed at more 180 modest levels under the transcriptional control of the relatively weak MET25 promoter 14 ( Figure 1B ).
181
This model allows testing low polyQ toxicity without altering the carbon source. High expression of 182 polyQ expanded Htt ex1 results in polyQ length-dependent formation of cytoplasmic aggregates that can 183 be observed using fluorescent microscopy ( Figure 1C ).
185
Misfolded polyQ proteins associated with the polyglutamine disease spinocerebellar ataxia disrupt 186 assembly of the SAGA complex and SAGA-dependent transcription 40 . The ensuing phenotype 187 resembles those associated with deletions of SAGA complex components. Sca7, the protein 188 responsible, is a subunit of the hSAGA complex. Thus, its crucial role in SAGA function is expected. To 189 investigate the relationship between Htt ex1 , a protein that is not part of the acetyltransferases 190 complexes, we examined genetic interactions of Htt ex1 with deletions of NuA4 (eaf1Δ, eaf6Δ, yaf9Δ) 191 and SAGA (ada2Δ, spt8Δ, ubp8Δ) components (Figure 2A ). Expanded polyQ expression displayed 192 increased growth defects with deletion of the SAGA components Ada2 and Ubp8, but not Spt8. 72Q 193 expression only modestly affected growth in one of the NuA4 related deletions, eaf6Δ. For Tra1, we 194 employed a previously characterized loss-of-function mutant of TRA1 (tra1-F3744A) that carries a 195 mutation in the C-terminal FATC domain 65 . tra1-F3744A displayed strong growth defects in presence of 196 expanded 72Q in both plate and liquid growth assays ( Figure 2B ). Supporting these data, polyQ 197 expression sensitized cells to stresses that result in slow growth of strains carrying TRA1 mutations, i.e.
198
calcofluor white, growth at 39 0 C, 5% ethanol, MMS and caffeine 59 ( Figure 2C ). Expression of expanded 199 polyQ proteins was also associated with decreased activity from SAGA regulated promoters (HIS4 and 200 PHO5) ( Figure 2D ) and histone H3 acetylation ( Figure 2E ), implicating that polyQ affects SAGA 201 function in yeast.
203
Accumulation of misfolded polyQ expansions increase TRA1 expression
204
We previously observed that Tra1 bearing mutations in its PI3K domain (tra1 Q3 ) decrease nuclear 205 localization of the protein 59 . We therefore assessed whether expressing polyQ expansion affects Tra1 206 localization using confocal microscopy. We found that expanded polyQ expression (72Q-ymsGFP) did 207 not change the nuclear localization of fluorescently tagged Tra1 (yemRFP-Tra1) ( Figure 3 ).
208
Consequently, polyQ possibly alters SAGA function independently of Tra1 sequestration into 209 cytoplasmic polyQ inclusions. Cells also respond to the defective tra1 Q3 allele by increasing the 210 transcription of the TRA1 gene 59 . We assayed expression from the TRA1 promoter to evaluate whether 211 expanded polyQ results in a Tra1 defect that also feedbacks to increase TRA1 expression. As shown in 212 Figure 4A , we found a ~2.5 fold increase in TRA1 expression of a TRA1-promoter LacZ fusion upon 213 expression of 72Q compared to the non-toxic 25Q. Increased transcription was also observed from 214 promoters of other components of SAGA and NuA4, i.e. NGG1, SPT7 and EAF1, but not for the control 215 gene PGK1 as was the case for tra1 Q3 59 ( Figure 4A ). We also observed that the polyQ-induced 216 increase in TRA1 expression was abolished when cells expressing 72Q were treated with the HDAC 217 inhibitor trichostatin A (TSA) ( Figure 4B ), suggesting that changes in chromatin remodeling the regulate 218 TRA1 expression in the presence of polyQ expansion. As a consequence of increased mRNA levels,
219
Tra1 protein abundance increased upon expression of 72Q ( Figure 4C ). These results suggest that 220 expanded polyQ impairs Tra1 function inducing a feedback mechanism to cope with disrupted 221 SAGA/NuA4 function. As shown in Figure 4D , the increased TRA1 expression was specific to polyQ
222
and was not observed with other stressors that result in protein misfolding, such as induction of 223 endoplasmic reticulum stress by tunicamycin, heat shock, oxidative stress caused by H 2 O 2, or 224 perturbation of cell wall integrity by calcofluor white ( Figure 4D ). Moreover, expression of α-synuclein,
225
another disease causing misfolded protein, reduced TRA1 promoter activity, indicating that various 226 misfolded proteins differentially impact TRA1 transcriptional regulation ( Figure 4E ). Interestingly,
227
disruption of the SAGA/NuA4 complex activity by deleting GCN5, SPT20 or EAF3 did not cause TRA1 228 upregulation ( Figure 4F ). These results suggest that the upregulation of TRA1 by misfolded polyQ is 229 not solely a consequence of disruption of the SAGA complex.
231
TOR1 signaling regulates polyQ toxicity
232
Our previous genetic screen highlighted a potential role for Tra1 in stress responses 47 , including the 233 control of cellular homeostasis by the TORC1 (Target of Rapamycin Complex 1) regulated signaling 234 cascades that link nutrient availability to cell growth and division. In this screen, a tra1 mutant displayed 235 a synthetic slow growth phenotype with a deletion of tor1 47 . Since data in mammalian cells support both 236 a protective and adverse role for TORC1 in HD 66-71 , we tested the effect of modulating TORC1 activity 237 on polyQ toxicity in yeast. First, we determined the effects of TORC1 inhibition using rapamycin ( Figure   238 5A and B). We found that rapamycin treatment significantly reduced growth of cells expressing 239 expanded 103Q protein in both solid and liquid media assays. Interestingly, rapamycin treatment did 240 not increase polyQ aggregation ( Figure 5C ). This result argues against a protective role for TOCR1 241 inhibition by rapamycin through stimulating polyQ aggregate removal through autophagy 68 . Similar to 242 rapamycin, a hyperactive allele of TOR1 (TOR1 L2134M ) 72 also exacerbated polyQ toxicity ( Figure 5D and 243 E). The TOR1 mutant had no effect on the toxicity of TDP-43 ( Figure S2 ), a protein linked to 244 amyotrophic lateral sclerosis (ALS) 73 , indicating that the role of TORC1 may diverge in different 245 diseases. TORC1 hyperactivation did not prevent the formation of polyQ aggregates ( Figure 5F ).
246
These data indicate that precise regulation of TORC1 signaling is crucial for cells to cope with polyQ 247 expansion. TORC1 regulates translation and ribosome biogenesis in both yeast and mammals.
248
Incidentally, cells expressing 72Q displayed increased sensitivity to the translational inhibitor 249 cycloheximide ( Figure 5G ) and decreased expression of ribosomal protein genes ( Figure 5H) 
328
We show that polyQ expansions affect Tra1 function and increase expression of TRA1 (Figure 4 ).
329
PolyQ expansions and expression of the tra1 Q3 mutant allele 59 are the only experimental conditions 330 identified to date that increase TRA1 expression. Interestingly, polyQ-induced TRA1 expression 331 requires Sfp1 (Figure 8 
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